Table 3 Comparative analysis between pathologic T3a and T3b patients according to SVI status on MRI.
N (%) or Mean ± SD | pT3a (N = 290) | pT3b (N = 159) | P | |
|---|---|---|---|---|
Negative SVI on MRI (N = 107) | Positive SVI on MRI (N = 52) | |||
Age, years | 67.4 ± 7.0 | 67.0 ± 7.2 | 66.9 ± 7.7 | 0.857 |
BMI, kg/m2 | 24.7 ± 3.1 | 24.6 ± 3.0 | 24.9 ± 3.3 | 0.831 |
Pre-biopsy PSA, ng/ml | 13.4 ± 11.3 | 26.6 ± 29.7 | 62.5 ± 92.5 | <0.001 |
RP GS category | <0.001 | |||
3 + 3 | 1 (0.3%) | 0 (0) | 0 (0) | |
3 + 4 | 78 (26.9%) | 7 (6.5%) | 1 (1.9%) | |
4 + 3 | 133 (45.9%) | 50 (46.7%) | 16 (30.8%) | |
≥4 + 4 | 78 (26.9%) | 50 (46.7%) | 35 (67.3%) | |
Pathologic LNI, yes | 7 (2.4%) | 21 (21.4%) | 18 (34.6%) | |
Pathologic PSM, yes | 112 (38.6%) | 43 (40.2%) | 40 (76.9%) | <0.001 |
BCR, yes | 37 (12.8%) | 25 (23.4%) | 20 (38.5%) | <0.001 |